Dapagliflozin decreases small dense low-density lipoprotein-cholesterol and increases high-density lipoprotein 2-cholesterol in patients with type 2 diabetes: comparison with sitagliptin

详细信息    查看全文

• 作者：Toshiyuki Hayashi ; Tomoyasu Fukui ; Noriko Nakanishi…
• 关键词：Dapagliflozin ; Sodium ; glucose co ; transporter ; 2 inhibitor ; Small dense low ; density lipoprotein ; cholesterol ; High ; density lipoprotein 2 ; cholesterol ; Lipoprotein subspecies
• 刊名：Cardiovascular Diabetology
• 出版年：2017
• 出版时间：December 2017
• 年：2017
• 卷：16
• 期：1
• 全文大小：887KB
• 刊物主题：Diabetes; Angiology; Cardiology;
• 出版者：BioMed Central
• ISSN：1475-2840
• 卷排序：16

文摘

BackgroundThe sodium-glucose co-transporter-2 (SGLT-2) inhibitors have been reported to increase both low-density lipoprotein (LDL) and high-density lipoprotein (HDL)-cholesterol (C). This study aimed to determine how SGLT-2 inhibitors affect LDL and HDL-C subspecies.